In addition, Wang et al. showed that miR-522 can target BRCA1 in TNBC, where its overexpression predicted reduced overall patient survival and a higher incidence of lymph node metastasis [35]. Here, BRCA1 is linked to metastatic malignant neoplasm in the lymph nodes.